MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with R

Raloxifene

Raloxifene 60mg tablets

No stability information

Stability notes for Raloxifene 60mg tablets

There are no stability notes for this medicine.

Suppliers (7) of Raloxifene 60mg tablets
Raloxifene 60mg tablets (A A H Pharmaceuticals Ltd)
Raloxifene 60mg tablets (Accord-UK Ltd)
Raloxifene 60mg tablets (Alliance Healthcare (Distribution) Ltd)
Raloxifene 60mg tablets (Aspire Pharma Ltd)
Raloxifene 60mg tablets (Bristol Laboratories Ltd)
Raloxifene 60mg tablets (Medihealth (Northern) Ltd)
Raloxifene 60mg tablets (Somex Pharma)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.